Order Article Reprints

Sokolenko AP, Moiseyenko FV, Iyevleva AG, Ivantsov AO, Dolmatov GD, Shelekhova KV, Gulo EV, Topal AX, Artemieva EV, Abduloeva NH, et al. Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients. International Journal of Molecular Sciences. 2023; 24(3):1870. https://doi.org/10.3390/ijms24031870

Sokolenko, Anna P., Fedor V. Moiseyenko, Aglaya G. Iyevleva, Alexandr O. Ivantsov, Georgiy D. Dolmatov, Ksenia V. Shelekhova, Elizaveta V. Gulo, Anastasya X. Topal, Elizaveta V. Artemieva, Nuriniso H. Abduloeva, and et al. 2023. "Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients" International Journal of Molecular Sciences 24, no. 3: 1870. https://doi.org/10.3390/ijms24031870

Sokolenko, A. P., Moiseyenko, F. V., Iyevleva, A. G., Ivantsov, A. O., Dolmatov, G. D., Shelekhova, K. V., Gulo, E. V., Topal, A. X., Artemieva, E. V., Abduloeva, N. H., Rysev, N. A., Barsova, D. A., Levchenko, N. V., Volkov, N. M., Egorenkov, V. V., Moiseyenko, V. M., & Imyanitov, E. N. (2023). Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients. International Journal of Molecular Sciences, 24(3), 1870. https://doi.org/10.3390/ijms24031870